Protalix’s drug, Eyelea, was approved after hours this afternoon for Gaucher’s Disease. I wrote a bullish note about it here. Of course I off-loaded my position in early April at $6.38 and missed the move later in the month into the $7s. It closed today at $6.19 after dipping as low as $5.80. In AH trading it is back in the high $7s. I will be looking to take a short position on this tomorrow.